Market Cap

Hikma Pharmaceuticals plc Market Capitalization:

£3.37 Billion

GBP as of Jan. 1, 2026

US$4.54 Billion

business Hikma Pharmaceuticals plc Company Profile

Hikma Pharmaceuticals plc Main Stock Listing

LSE: HIK

Market Capitalization History of Hikma Pharmaceuticals plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Hikma Pharmaceuticals plc market cap

Date Market Cap YoY Change
Jan. 1, 2026 £3.37 B -27.09%
Jan. 1, 2025 £4.63 B 12.55%
Jan. 1, 2024 £4.11 B 12.22%
Jan. 1, 2023 £3.66 B -19.42%
Jan. 1, 2022 £4.54 B -13.38%
Jan. 1, 2021 £5.25 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Hikma Pharmaceuticals plc Categories

United Kingdom languages Healthcare languages Drug Manufacturers—Specialty & Generic
United Kingdom Healthcare United Kingdom Drug Manufacturers—Specialty & Generic

Stocks & Indices

Hikma Pharmaceuticals plc has the following listings and related stock indices.


Stock: LSE: HIK

Stock: FSX: H5P

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.